Skip to main content

Advertisement

SpringerLink
Log in

Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

To evaluate whether continuous subcutaneous insulin infusion (CSII) may have any advantage over multiple daily injections (MDI) on glycemic control and treatment satisfaction in young patients with Type 1 diabetes in transition to an adult diabetes center. The study population consisted of 125 patients on MDI; 38 out of the 43 patients considered eligible for CSII completed the study and the 82 remaining on MDI served as control group. Glycemic control and treatment satisfaction [diabetes treatment satisfaction questionnaire (DTSQ)] were evaluated in all patients at baseline and after 12 weeks. At baseline, the two groups were well matched for demographic characteristics and glycemic control. DTSQ score was lower in CSII group (21.1 ± 8.8 vs. 25.1 ± 7.1, P = 0.011). After 12 weeks, a similar decrease in HbA1C was observed in both groups [difference −0.3 % (95 % CI −0.6 to 0.1, P = 0.847)]. Mean amplitude glucose excursions, blood glucose standard deviation, and overall hypoglycemia were significantly reduced in CSII group. DTSQ overall score increased in CSII and decreased in MDI (difference between groups = 9.9, 95 % CI 8.0–12.0, P < 0.001), while perceived hyperglycemia and hypoglycemia decreased in CSII compared with MDI (difference: −2.5 and −2.0, respectively, P < 0.001 for both). Among young Type 1 diabetic patients in transition from Pediatrics, CSII showed a similar efficacy in reducing HbA1c compared with MDI, with less hypoglycemia and glycemic excursions, and was better in improving overall treatment satisfaction and the rate of perceived hyperglycemia and hypoglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. D.B. Petitti, G.J. Klingensmith, R.A. Bell, J.S. Andrews, D. Dabelea, G. Imperatore, S. Marcovina, C. Pihoker, D. Standiford, B. Waitzfelder, E. Mayer-Davis, SEARCH for Diabetes in Youth Study Group: Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J. Pediatr. 155, 668–672 (2009)

    Article  CAS  PubMed  Google Scholar 

  2. The DCCT Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993)

    Article  Google Scholar 

  3. K.S. Bryden, D.B. Dunger, R.A. Mayou, R.C. Peveler, H.A. Neil, Poor prognosis of young adults with Type 1 diabetes: a longitudinal study. Diabetes Care 26, 1052–1057 (2003)

    Article  PubMed  Google Scholar 

  4. V.S. Helgeson, K.A. Reynolds, P.R. Snyder, D.K. Palladino, D.J. Becker, L. Siminerio, O. Escobar, Characterizing the transition from paediatric to adult care among emerging adults with Type 1 diabetes. Diabet. Med. 30, 610–615 (2013)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. D.S. Lotstein, M. Seid, G. Klingensmith, D. Case, J.M. Lawrence, C. Pihoker, D. Dabelea, E.J. Mayer-Davis, L.K. Gilliam, S. Corathers, G. Imperatore, L. Dolan, A. Anderson, R.A. Bell, B. Waitzfelder, SEARCH for Diabetes in Youth Study Group: Transition from pediatric to adult care for youth diagnosed with Type 1 diabetes in adolescence. Pediatrics 131, e1062–e1070 (2013)

    Article  PubMed  Google Scholar 

  6. J.H. DeVries, F.J. Snoek, P.J. Kostense, N. Masurel, R.J. Heine, A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in Type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25, 2074–2080 (2002)

    Article  CAS  PubMed  Google Scholar 

  7. J.L. Colquitt, C. Green, M.K. Sidhu, D. Hartwell, N. Waugh, Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health. Technol. Assess. 8, 1–171 (2004)

    Google Scholar 

  8. R.P. Hoogma, P.J. Hammond, R. Gomis, D. Kerr, D. Bruttomesso, K.P. Bouter, K.J. Wiefels, H. de la Calle, D.H. Schweitzer, M. Pfohl, E. Torlone, L.G. Krinelke, G.B. Bolli, 5-Nations Study Group: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet. Med. 23, 141–147 (2005)

    Article  Google Scholar 

  9. EQuality1 Study Group–Evaluation of QUALITY of Life and Costs in Diabetes Type 1, A. Nicolucci, A. Maione, M. Franciosi, R. Amoretti, E. Busetto, F. Capani, D. Bruttomesso, P. Di Bartolo, A. Girelli, F. Leonetti, L. Morviducci, P. Ponzi, E. Vitacolonna, Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet. Med. 25, 213–220 (2008)

    Article  CAS  PubMed  Google Scholar 

  10. J.C. Pickup, P. Hammond, NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance. Diabet. Med. 26, 1–4 (2009)

    Article  CAS  PubMed  Google Scholar 

  11. E.R. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-Jack, L. Fish, S.R. Heller, H. Rodriguez, J. Rosenzweig, R. Vigersky, Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society. Diabetes Care 36, 1384–1395 (2013)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. F.J. Service, G.D. Molnar, J.W. Rosevear, E. Ackerman, L.C. Gatewood, W.F. Taylor, Mean amplitude of glycemic excursions: a measure of diabetic instability. Diabetes 19, 644–655 (1970)

    CAS  PubMed  Google Scholar 

  13. A. Nicolucci, R. Giorgino, D. Cucinotta, G. Zoppini, M. Muggeo, S. Squatrito, A. Corsi, S. Lostia, L. Pappalardo, E. Benaduce, A. Girelli, F. Galeone, A. Maldonato, G. Perriello, P. Pata, G. Marra, G.A. Coronel, Validation of the Italian version of the WHOWELL-Being questionnaire (WHO_WBQ) and the WHO-Diabetes treatment satisfaction questionnaire (WHO_DTSQ). Diabetes Nutr. Metab. 17, 235–243 (2004)

    CAS  PubMed  Google Scholar 

  14. E.L. Feldman, M.J. Stevens, P.K. Thomas, M.B. Brown, N. Canal, D.A. Greene, A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17, 1281–1289 (1994)

    Article  CAS  PubMed  Google Scholar 

  15. R.P. Hoogma, A.J. Spijker, M. van Doorn-Scheele, T.T. van Doorn, R.P. Michels, R.G. van Doorn, M. Levi, J.B. Hoekstra, Quality of life and metabolic control in patients with diabetes mellitus Type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth. J. Med. Nov. 62, 383–387 (2004)

    CAS  Google Scholar 

  16. A. Peters, L. Laffel, The American Diabetes Association Transitions Working Group.: Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems. Diabetes Care 34, 2477–2485 (2011)

    Article  PubMed Central  PubMed  Google Scholar 

  17. H.C. Yeh, T.T. Brown, N. Maruthur, P. Ranasinghe, Z. Berger, Y.D. Suh, L.M. Wilson, E.B. Haberl, J. Brick, E.B. Bass, S.H. Golden, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann. Intern. Med. 157, 336–347 (2012)

    Article  PubMed  Google Scholar 

  18. American Diabetes Association, Standards of medical care in diabetes 2013. Diabetes Care 36, S11–S66 (2013)

    Article  PubMed Central  Google Scholar 

  19. L. Hanberger, U. Samuelsson, B. Lindblad, J. Ludvigsson, A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care 31, 927–929 (2008)

    Article  PubMed  Google Scholar 

  20. C.E. de Beaufort, P.G. Swift, C.T. Skinner, H.J. Aanstoot, J. Aman, F. Cameron, P. Martul, F. Chiarelli, D. Daneman, T. Danne, H. Dorchy, H. Hoey, E.A. Kaprio, F. Kaufman, M. Kocova, H.B. Mortensen, P.R. Njølstad, M. Phillip, K.J. Robertson, E.J. Schoenle, T. Urakami, M. Vanelli, Hvidoere Study Group on Childhood Diabetes 2005. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care 30, 2245–2250 (2007)

    Article  PubMed  Google Scholar 

  21. E.A. Doyle, S.A. Weinzimer, A.T. Steffen, J.A. Ahern, M. Vincent, W.V. Tamborlane, A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27, 1554–1558 (2004)

    Article  CAS  PubMed  Google Scholar 

  22. G.B. Bolli, D. Kerr, R. Thomas, E. Torlone, A. Sola-Gazagnes, E. Vitacolonna, J.L. Selam, P.D. Home, Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in Type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care 32, 1170–1176 (2009)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. K. Esposito, P. Chiodini, A. Capuano, M. Petrizzo, M.R. Improta, D. Giugliano, Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for Type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care 35, 2698–2705 (2012)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. K. Esposito, A. Capuano, D. Giugliano, Humalog (lispro) for Type 2 diabetes. Expert Opin Biol Ther 12, 1541–1550 (2012)

    Article  CAS  PubMed  Google Scholar 

  25. D. Bruttomesso, D. Crazzolara, A. Maran, S. Costa, M. Dal Pos, A. Girelli, G. Lepore, M. Aragona, E. Iori, U. Valentini, S. Del Prato, A. Tiengo, A. Buhr, R. Trevisan, A. Baritussio, In Type 1 diabetic patients with good glycemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet. Med. 25, 326–332 (2008)

    Article  CAS  PubMed  Google Scholar 

  26. I.B. Hirsch, B.W. Bode, S. Garg, W.S. Lane, A. Sussman, P. Hu, O.M. Santiago, J.W. Kolaczynski, Insulin Aspart CSII/MDI Comparison Study Group: Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in Type 1 diabetic patients previously treated with CSII. Diabetes Care 28, 533–538 (2005)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical, Surgical, Neurological, Metabolic Sciences and Geriatrics, Second University of Naples, Piazza L. Miraglia no 2, 80138, Naples, Italy

    Maria Ida Maiorino, Giuseppe Bellastella, Michela Petrizzo, Maria Rosaria Improta, Clementina Brancario, Filomena Castaldo, Laura Olita & Dario Giugliano

  2. Department of Clinical and Experimental Medicine, Second University of Naples, via Pansini 5, 80131, Naples, Italy

    Katherine Esposito

  3. Unit of Diabetology, University Hospital at Second University of Naples, 80138, Naples, Italy

    Maria Ida Maiorino

Authors
  1. Maria Ida Maiorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Bellastella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michela Petrizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Rosaria Improta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clementina Brancario
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Filomena Castaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laura Olita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dario Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Katherine Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Ida Maiorino.

Additional information

This study was conducted for the Management and Technology for Transition (METRO) Study Group.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maiorino, M.I., Bellastella, G., Petrizzo, M. et al. Treatment satisfaction and glycemic control in young Type 1 diabetic patients in transition from pediatric health care: CSII versus MDI. Endocrine 46, 256–262 (2014). https://doi.org/10.1007/s12020-013-0060-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-0060-6

Keywords

Search

Navigation